ClinicalTrials.Veeva

Menu

Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectatic Facial Conditions

H

Hawler Medical University

Status

Completed

Conditions

Rosacea, Erythematotelangiectatic

Treatments

Device: Nd:YAG laser 1064 nm

Study type

Interventional

Funder types

Other

Identifiers

NCT06908915
KHCMS: 12/241-2023

Details and patient eligibility

About

The goal of this clinical study is to assess the effectiveness of Nd:YAG laser 1064 nm in the long pulse mode in the treatment of signs of rosacea including the erythema of the face and telangiectasia. The used parameter of this laser was of very low energy (spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 millijoules (mJ) and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval) and also its was expected to have minimal adverse effects.

Enrollment

30 patients

Sex

All

Ages

32 to 52 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with rosacea (erythemato-telangiectatic type)

Exclusion criteria

  • Other clinical types of rosacea
  • Pregnancy and lactation in females
  • History of malignancies
  • History of photosensitivity
  • History of any other modalities of treatment of rosacea over last 6 months

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Definition: rosacea patients. Limit: 30 patients
Experimental group
Description:
Patients with rosacea received treatment with Nd:YAG laser with spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 mJ and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval
Treatment:
Device: Nd:YAG laser 1064 nm

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems